Marc Brehme
Dr. Marc Brehme unites ~20 years of experience in molecular biomedicine, life sciences and biotechnology in diverse disease areas and technology platforms with management expertise in the biotech and biopharma sectors.
Dr. Brehme’s interests center on the use of innovative approaches to tackling bottlenecks and challenges in personalised medicine. Dr. Brehme is committed within the ÖPPM to promote scientific avenues toward personalised medicine in general, and especially also as regards the positioning, communication and integration of molecular systems biology methodologies, synthetic biology technologies and associated capabilities in enabling the next generation of designed therapeutics for personalised medicine. Focusing on fostering new technologies, his focus is on consulting ventures in biotechnology and biopharma towards translational and commercial success - and ultimately medical impact towards meeting patients’ needs.
Additional Information: